"Aetna is a growth company," the analyst wrote. "While the perception leans against that claim, Aetna did a very good job of laying out its rationale for that assertions." Medicaid is the company's fastest growth segment over the past four years.
Evolution Of Mix
Related Links: Deutsche Initiates Coverage On Health Stocks As National Health Insurance Debate Rages On In The Wake Of Failed Merger With Aetna, Humana Regains Outperform Rating From Oppenheimer _________ Image Credit: By GK tramrunner229 - Own work, CC BY-SA 3.0, via Wikimedia CommonsRaskin continued with four simple facts to support his thesis:
Raskin further noted that Aetna's management was able to shift the company over the past few years to one where it is positioned today to benefit from a higher mix of revenue from growth opportunities. Of particular note, the company "has consciously pivoted" toward the government segment, and "empirical evidence shows clear out-performance" in this segment.
Raskin added that Aetna has done a "remarkable job" over the years and the company's story isn't recognized by investors as it should.
Bottom line, the analyst believes Aetna is still well positioned for continued growth in the broader managed care landscape and expect "strong returns to continue in the future."
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.